本ウェブサイトでは、ユーザーにウェブサイト上のサービスを最適な状態でお届けするためCookieを使用しています。ブラウザの設定(Cookieの無効化等)をそのまま変更せずに閲覧される場合は、弊社ウェブサイト上の全ページでCookieを受信することに同意したものとみなします。詳細は、弊社プライバシーポリシーをご覧ください。
本ウェブサイトでは、ユーザーにウェブサイト上のサービスを最適な状態でお届けするためCookieを使用しています。ブラウザの設定(Cookieの無効化等)をそのまま変更せずに閲覧される場合は、弊社ウェブサイト上の全ページでCookieを受信することに同意したものとみなします。詳細は、弊社プライバシーポリシーをご覧ください。
採用企業 | ICE S.p.A |
勤務地 | 福島県, いわき市 |
雇用形態 | 契約 |
給与 | 経験考慮の上、応相談 ~ 500万円 |
Executive Assistant
Executive assistant will directly report to the General Manager (= President) of the Japanese Subsidiary and will provide administrative and secretarial support to the president and support/coordinate a variety of programs/activities for theGM office.
Key Responsibilities
職務経験 | 3年以上 |
キャリアレベル | 中途経験者レベル |
英語レベル | ビジネス会話レベル |
日本語レベル | ネイティブ |
その他言語 | イタリア語 - 日常会話レベル |
Italian is a good to have, not mandatory | |
最終学歴 | 短大卒: 準学士号 |
現在のビザ | 日本での就労許可が必要です |
Competency:
Education/Experience:
Language Ability:
English and Japanese : Fluency Required
Italian : Business Level will be considered a plus
Location
The Executive assistant will be based in Iwaki / Fukushima province.
※ Commuting allowance will be provided as per company policy
※ Relocation support will be considered depending on the current location of the candidate
*****************
ICE Group is a worldwide multinational Company specialized in natural origin Bile Acids derivates. Founded more than 60 years ago and headquartered in Reggio Emilia (Italy), the Company is now one of the main global players in natural origin bile -related products, with a network of specialist facilities and subsidiaries in Europe, Asia, Oceania, North and South America, which collect and process raw materials safely and securely.
ICE’s core business includes the manufacturing of Active pharmaceutical ingredients and final dosage forms along with derivatives linked to its raw materials collection network. Its global and vertical integrated business structure allows the Company to collect raw materials and process it into ingredients, the most important of which is the Ursodeoxycholic Acid (UDCA), a key ingredient in drugs treating liver diseases and gallstones.
On top of UDCA production, ICE is also committed to enhance the production of almost 20 other APIs that are currently manufactured in our sites in Italy (Reggio Emilia, Basaluzzo), Japan (Iwaki), India (Raichur) and New Zealand, while the FDF production is located in our site in Ivrea (Italy).
ICE has 5 R&D centres, spread across Italy, United Kingdom, India and New Zealand, which allow the Company continuous growth, through the constant development in bile derivatives field as well as in innovative research and development in plant-based bile acid chemistry along with consolidated expertise in carbohydrates. ICE’s Innovation is strongly supported by cutting edge collaboration with worldwide top Universities, leading the identification of bile acid-based molecules and lead candidates for highly significant unmet diseases like Parkinson’s, Alzheimer’s, NASH.
Since October 2019, ICE Group is owned by Advent International, one of the largest and most experienced global private equity investors, that started a vigorous M&A Plan in API and pharmaceutical business.
Corporate Cultural Pillars
Our Cultural Pillars shape the foundations of how we operate as a growing global enterprise. Our Cultural Pillars of Unity, Evolution and Achievement are at the forefront of how we conduct business.
Equal Opportunities
ICE PHARMA operates according to impartiality and does not tolerate any type of discrimination based on age, language, gender, sexual orientation, health status, disability, ethnicity, nationality, political views and religious beliefs. Our recruitment practices are inclusive and free from discrimination.
雇用形態 | 契約 |
給与 | 経験考慮の上、応相談 ~ 500万円 |
業種 | 医薬品 |
会社の種類 | 中小企業 (従業員300名以下) - 外資系企業 |
外国人の割合 | 外国人 半数 |